JSA
GSK icon

Jacobson & Schmitt Advisors’s GSK GSK Stock Holding History

Jacobson & Schmitt Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,864
Closed -$330K – 40
2015
Q3 		$330K Buy
+6,864
New +$357K 0.33% 33

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jacobson & Schmitt Advisors's GSK Position: Q4 2015 in Review

Jacobson & Schmitt Advisors sold out of GSK (GSK) in Q4 2015, closing a stake of 6,864 shares — an estimated $330K sold.

Jacobson & Schmitt Advisors first reported a position in GSK in Q3 2015 and held it in 1 quarter. The position peaked at $330K in Q3 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • Jacobson & Schmitt Advisors reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
  • Jacobson & Schmitt Advisors sold 6,864 GSK shares in Q4 2015, an estimated $330K.
  • Jacobson & Schmitt Advisors first reported a position in GSK in Q3 2015 and held it in 1 quarter.
  • Jacobson & Schmitt Advisors's GSK position peaked at $330K in Q3 2015.
  • 719 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Jacobson & Schmitt Advisors's 13F filing for Q4 2015, filed 9 Feb 2016.